Updated time: 2021-02-26 14:44:31
28A-1090116
2021-02-26
USP patent pending
Disclosed herein are methods for selecting an antibody fragment specific to an influenza virus. The influenza virus may be influenza virus type A (IAV) or influenza virus type B (IBV). Also disclosed herein are the selected antibodies, and the uses thereof in the diagnosis of influenza virus infection.
- VAntibodies are not limited to animal immune response, can produce a wide range of antibodies in a short time.
- Produce discriminating antibodies even against highly similar antigens
- Use different antibody combinations to detect different virus subtypes and avoid misjudgment.
- Rapid influenza detection kits.
- Rapid general procedure in developing LFIA-based rapid detection tests (RIDTs).
- Rapid general procedure in developing diagnostic antibodies.

Fig1. Representative NPs from the Influenza Research Data Base and the anti-NP.

Fig2. LFIA results and detection limits for anti-NP IgG1s binding to respective NPs.
An-Suei Yang, Chung-Ming Yu, Ing-Chein CHEN, Chao-ping TUNG, Hung-Pin Peng
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

METHOD FOR SELECTING ANTIBODY FRAGMENTS, RECOMBINANT ANTIBODIES PRODUCED THEREFROM, AND USES THEREOF